News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
Thursday, October 20, 2022Ayala Pharmaceuticals Inc a clinicalstage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers and Advaxis Inc a biotechnology company devoted to the dis...
Grifols inaugurates new state-of-the-art manufacturing plant in Ireland to meet growing global demand for plasma medicines
Thursday, October 20, 2022Grifols a global leader in plasmaderived medicines today will inaugurate a new albumin purification and filling plant at its global manufacturing and supply hub in Dublin Ireland a milestone in the continuing expansion of a site that plays an increa...
Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World
Wednesday, October 19, 2022Evotec SE today announced the launch of the first commercial version of its PanOmics data analysis platform PanHunter at BioIT World October in Berlin Germany PanHunter is Evotecs PanOmics data access and analytics platform and was developed and use...
GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D
Wednesday, October 19, 2022GSK plc and Tempus a USbased precision medicine company have entered into a threeyear collaboration agreement that provides GSK with access to Tempus AIenabled platform including its library of deidentified patient data Through its leading Artificial...
SHINE Gets Dutch Approval for Project to Improve Patient Access to Promising New Nuclear Medicine
Tuesday, October 18, 2022SHINE Technologies a nextgeneration fusion technology company and SHINE Europe announced today that the Dutch government has approved a substantial grant proposal to develop a plan to produce a variety of terbium isotopes for use in nuclear medicine...
Exacis Biotherapeutics Grants Eterna Therapeutics an Option to License Up To Four Allogeneic Ipsc-derived NK And T Cell Therapies
Tuesday, October 18, 2022Exacis Biotherapeutics Inc a developmentstage immunooncology company working to harness the immune system to cure cancer today announced that it has signed an option agreement with Eterna Therapeutics Inc Eterna providing Eterna the right to license...
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults With CLL
Saturday, October 15, 2022BeiGene a global biotechnology company focused on developing innovative and affordable oncology medicines to improve treatment outcomes and access for patients worldwide today announced that the Committee for Medicinal Products for Human Use CHMP of...
Emergex Acquires Intradermal and Patch Drug Delivery Technology with Its Manufacturing Equipment from Zosano Pharma
Thursday, October 13, 2022Emergex Vaccines Holding Limited a clinical stage biotechnology company addressing major global infectious diseases through the development of fully synthetic CD T cell Adaptive Vaccines announces that it has acquired the assets of Zosano Pharma Corp...
TILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian Cancer
Wednesday, October 12, 2022TILT Biotherapeutics a clinicalstage biotechnology company developing cancer immunotherapies announces that the first US patient has been dosed in its ovarian cancer trial NCT using its oncolytic adenovirus TILT that has the potential to be firstincl...
LabVantage Solutions and Biomax Informatics Merge to Create Innovative Capabilities for the Life Science and Bio Manufacturing Industries
Wednesday, October 12, 2022LabVantage Solutions Inc the leading provider of laboratory informatics solutions and services including purposebuilt LIMS solutions that allow labs to go live faster and at a lower total cost and Biomax Informatics AG a software solutions and servic...
